Cargando…

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion

Inflammation plays a key role during cardiac hypertrophy and the development of heart failure. Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that is expressed in the heart and may play a crucial role in cardiac remodeling. Based on the evidence that IL-10 potentially reduces pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stafford, Nicholas, Assrafally, Farryah, Prehar, Sukhpal, Zi, Min, De Morais, Ana M., Maqsood, Arfa, Cartwright, Elizabeth J., Mueller, Werner, Oceandy, Delvac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662881/ https://www.ncbi.nlm.nih.gov/pubmed/33192505 http://dx.doi.org/10.3389/fphar.2020.559220

Ejemplares similares

The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice
por: Omede, Ameh, et al.
Publicado: (2016)

The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
por: Mohamed, Tamer M. A., et al.
Publicado: (2016)

Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains
por: Zi, Min, et al.
Publicado: (2019)

Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU‐MP‐1, protects the heart against adverse effects during pressure overload
por: Triastuti, Efta, et al.
Publicado: (2019)

The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-α signalling in cardiomyocytes
por: Mohamed, Tamer M.A., et al.
Publicado: (2014)

PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
por: Stafford, Nicholas, et al.
Publicado: (2021)

Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice
por: Nugroho, Ardiansah Bayu, et al.
Publicado: (2022)

Isoproterenol infusion in septic shock
por: Wiwanitkit, Viroj
Publicado: (2015)

Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Bui, Thuy Anh, et al.
Publicado: (2023)

Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
por: Hegab, Zeinab, et al.
Publicado: (2017)

Isoproterenol infusion and microcirculation in septic shock
por: Wiramus, S, et al.
Publicado: (2014)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival
por: Robertson, Abigail, et al.
Publicado: (2017)

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
por: Chakraborty, Songjukta, et al.
Publicado: (2015)

Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS‐dependent mechanism
por: Lewis, Sophronia, et al.
Publicado: (2017)

Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction
por: Ulm, Susanne, et al.
Publicado: (2014)

The Cross-Talk Between the TNF-α and RASSF-Hippo Signalling Pathways
por: Oceandy, Delvac, et al.
Publicado: (2019)

Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats
por: Yuan, Yonggang, et al.
Publicado: (2017)

No coronary artery occlusion in septic shock: Isoproterenol infusion should not be discouraged
por: Leone, Marc, et al.
Publicado: (2015)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy
por: Gan, Mailin, et al.
Publicado: (2020)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Allylmethylsulfide, a Sulfur Compound Derived from Garlic, Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats
por: Mohammed, Soheb Anwar, et al.
Publicado: (2020)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Puerarin attenuates isoproterenol-induced myocardial hypertrophy via inhibition of the Wnt/β-catenin signaling pathway
por: Wang, Xiaoying, et al.
Publicado: (2022)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Electrical storm reversible by isoproterenol infusion in a striking case of early repolarization
por: Bernard, Anne, et al.
Publicado: (2009)

Coronary Artery Spasm During Catheter Ablation Caused by the Intravenous Infusion of Isoproterenol
por: Okuya, Yoshiyuki, et al.
Publicado: (2020)

Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
por: Shimano, Ken, et al.
Publicado: (2021)

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
por: Al-rasheed, Nouf M, et al.
Publicado: (2015)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner
por: Zhang, Jingyao, et al.
Publicado: (2018)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis
por: Althurwi, Hassan N., et al.
Publicado: (2020)

Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy
por: KUBERAPANDIAN, Dharaniyambigai, et al.
Publicado: (2021)

Reduced expression of PMCA1 is associated with increased blood pressure with age which is preceded by remodelling of resistance arteries
por: Little, Robert, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gepur403gpu2p4k8dts8pnc933